Individualized homoeopathic medicines in treatment of chronic migraine: Double-blind, randomized, placebo-controlled, pilot trial

The Calcutta Homoeopathic Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patients suffering from chronic migraine, that is, headache on 15 or more days/month for more than 3 months, with a feature of migraine headache on at least 8 days/month (ICD-10-CM Code G43.709)
•2. Patients of 18-65 years of age and of either sex
•3. Patients who have not taken any treatment since at least 2 weeks for migraine
•4. Literate patients; can read Bengali and/or English
•5. Providing written informed consent to participate in the trial

•1. Patients suffering from the complications of migraine
•2. Patients who are undergoing treatment with non-steroidal anti-inflammatory drugs (NSAIDs), antiemetic, or oestrogen during 2 weeks prior to enrolment in the study
•3. Other uncontrolled or unstable systemic or psychiatric diseases and/or infections affecting quality of life
•4. Patients who are too sick for consultation
•5. Pregnant and puerperal women, and lactating mothers
•6. Substance abuse and/or dependence
•7. Self-reported immune-compromised state
•8. Undergoing homoeopathic treatment for any chronic disease within last 6 months.

发起方

The Calcutta Homoeopathic Medical College and Hospital